Vivo Capital’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Vivo Capital’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-6,495,416	Closed	-$97.3M	–	25
2016 Q2	$97.3M	Sell	6,495,416 -4,321	-0.1%	-$55.5K	26.57%	1
2016 Q1	$79.1M	Buy	+6,499,737	New	+$91.1M	19.84%	2

Vivo Capital's SGNT Position: Q3 2016 in Review

Vivo Capital sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 6,495,416 shares — an estimated $97.3M sold.

Vivo Capital first reported a position in SGNT in Q1 2016 and held it in 2 quarters. The position peaked at $97.3M in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

Vivo Capital reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
Vivo Capital sold 6,495,416 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $97.3M.
Vivo Capital first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q1 2016 and held it in 2 quarters.
Vivo Capital's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $97.3M in Q2 2016.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Vivo Capital's 13F filing for Q3 2016, filed 14 Nov 2016.